Vimarsana
Biggest News Aggregation in the World

Page 29 - Oche News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Oche. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Oche Today - Breaking & Trending Today

Chemed Co. (NYSE:CHE) Shares Sold by Trinity Street Asset Management LLP - Vimarsana News

Chemed Co. (NYSE:CHE) Shares Sold by Trinity Street Asset Management LLP

Trinity Street Asset Management LLP cut its stake in Chemed Co. (NYSE:CHE – Free Report) by 0.3% in the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 28,998 shares of the company’s stock after selling 95 shares during the quarter. Chemed comprises approximately 1.7% of […]

The Mysterious Moche Icon of the Iguana, Companion to the Sky God Wrinkle Face - Vimarsana News

The Mysterious Moche Icon of the Iguana, Companion to the Sky God Wrinkle Face

The iguana was an important animal in the mythology of the powerful Moche civilization.

Chemtrade Logistics Income Fund (CHE) To Go Ex-Dividend on September 28th - Vimarsana News

Chemtrade Logistics Income Fund (CHE) To Go Ex-Dividend on September 28th

Chemtrade Logistics Income Fund (TSE:CHE – Get Free Report) announced a monthly dividend on Wednesday, September 20th, Zacks reports. Investors of record on Friday, September 29th will be given a dividend of 0.05 per share on Thursday, October 26th. This represents a $0.60 annualized dividend and a dividend yield of ∞. The ex-dividend date is […]

Copeland Capital Management LLC Grows Stock Position in Chemed Co. (NYSE:CHE) - Vimarsana News

Copeland Capital Management LLC Grows Stock Position in Chemed Co. (NYSE:CHE)

Copeland Capital Management LLC raised its stake in Chemed Co. (NYSE:CHE – Free Report) by 10.2% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 145,794 shares of the company’s stock after purchasing an additional 13,526 shares during the period. Chemed comprises […]

Genentech and PeptiDream to co-develop radiopharmaceuticals in $1BN deal - Vimarsana News

Genentech and PeptiDream to co-develop radiopharmaceuticals in $1BN deal

The Roche-owned U.S. giant Genentech has teamed up with the Japanese biotech Peptidream to co-develop peptide-based radiopharmaceutical treatments.